Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2026-01-20 @ 3:16 PM
Study NCT ID:
NCT04103060
Status:
COMPLETED
Last Update Posted:
2020-11-24
First Post:
2019-09-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Tolerability Study of Cerdulatinib Gel, 0.37% in Adults With Vitiligo
Sponsor:
Dermavant Sciences GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-27
Start Date Type:
ACTUAL
Primary Completion Date:
2020-11-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-11-03
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-18
First Submit QC Date:
None
Study First Post Date:
2019-09-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-23
Last Update Post Date:
2020-11-24
Last Update Post Date Type:
ACTUAL